A Caballero

754 total citations
38 papers, 314 citations indexed

About

A Caballero is a scholar working on Oncology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A Caballero has authored 38 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Hematology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A Caballero's work include CAR-T cell therapy research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). A Caballero is often cited by papers focused on CAR-T cell therapy research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). A Caballero collaborates with scholars based in Spain, United States and Uruguay. A Caballero's co-authors include Javier Briones, Jorge Sierra, Silvana Novelli, Núria Martínez‐Cibrián, Alejandro Martı́n, Lucía López‐Corral, Rodrigo Martino, Guillermo Villacampa, Pere Barba and Gloria Iacoboni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

A Caballero

34 papers receiving 302 citations

Peers

A Caballero
Manpreet Chadha United States
Miriam Schulz Germany
Laetitia Da Meda France
Pauline Laly France
Marco Schupp United States
Lisa Wray United States
Julia Krzykalla Germany
Mohammed Jaloudi United States
Sisi Yu China
Manpreet Chadha United States
A Caballero
Citations per year, relative to A Caballero A Caballero (= 1×) peers Manpreet Chadha

Countries citing papers authored by A Caballero

Since Specialization
Citations

This map shows the geographic impact of A Caballero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Caballero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Caballero more than expected).

Fields of papers citing papers by A Caballero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Caballero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Caballero. The network helps show where A Caballero may publish in the future.

Co-authorship network of co-authors of A Caballero

This figure shows the co-authorship network connecting the top 25 collaborators of A Caballero. A scholar is included among the top collaborators of A Caballero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Caballero. A Caballero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caballero, A, Irene García‐Cadenas, Albert Esquirol, et al.. (2025). HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma. Blood. 145(16). 1788–1801.
2.
Bastos‐Oreiro, Mariana, Gloria Iacoboni, Vı́ctor Navarro, et al.. (2025). Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 9(2). e70077–e70077. 1 indexed citations
3.
4.
Solano, Carlos, Pedro Castro, Antonio Pérez‐Martínez, et al.. (2023). Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study. BMJ Open. 13(7). e071371–e071371. 2 indexed citations
5.
García‐Cadenas, Irene, Silvana Novelli, Silvana Saavedra, et al.. (2023). Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature. Transplantation and Cellular Therapy. 29(7). 473.e1–473.e6. 5 indexed citations
6.
Esquirol, Albert, Irene García‐Cadenas, Silvana Novelli, et al.. (2023). Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience. Annals of Hematology. 103(1). 321–334. 1 indexed citations
7.
Caballero, A, et al.. (2022). CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure. Frontiers in Immunology. 13. 904497–904497. 17 indexed citations
8.
9.
Caballero, A, et al.. (2022). Immune effector cell-associated neurotoxicity syndrome: A therapeutic approach in the critically ill. Medicina Intensiva (English Edition). 46(4). 201–212. 2 indexed citations
10.
Muntañola, Ana, Tycho Baumann, A Caballero, et al.. (2020). Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group. Annals of Hematology. 99(7). 1627–1634. 3 indexed citations
11.
Caballero, A, et al.. (2020). Síndrome de neurotoxicidad asociada a células inmunoefectoras: un enfoque terapéutico en el paciente crítico. Medicina Intensiva. 46(4). 201–212. 2 indexed citations
12.
García‐Cadenas, Irene, Silvana Novelli, Silvana Saavedra, et al.. (2020). Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching. Bone Marrow Transplantation. 56(4). 818–827. 26 indexed citations
13.
Caballero, A, et al.. (2018). The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma. OncoImmunology. 8(2). e1546543–e1546543. 5 indexed citations
14.
Novelli, Silvana, Irene García‐Cadenas, A Caballero, et al.. (2017). Allogeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphomas: a retrospective analysis of 77 cases. Annals of Hematology. 96(5). 787–796. 3 indexed citations
15.
Pablos‐Velasco, Pedro de, et al.. (2005). Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary Islands, Spain) and estimation of the prevalence of diabetes mellitus. Diabetes & Metabolism. 31(5). 457–462. 21 indexed citations
16.
Albareda, M., Mercedes Rigla, José Rodrı́guez-Espinosa, et al.. (2004). Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes. Diabetes Research and Clinical Practice. 68(3). 202–206. 23 indexed citations
17.
Caballero, A, et al.. (1998). Autoantibodies against Thyroid Hormones Can Lead to an Erroneous Diagnosis and Potentially Harmful Treatment. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 35(1). 152–153. 2 indexed citations
18.
Caballero, A, et al.. (1991). [Hepatic activity of glutathione transferase and bromsulphalein metabolism].. PubMed. 79(2). 112–6. 3 indexed citations
19.
Pérez, M., António Garrido, Ignacio Algarra, et al.. (1989). H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.. PubMed. 6(3). 204–18. 7 indexed citations
20.
Caballero, A, et al.. (1979). Modifications in nycthemeral rhythm of prolactin in human breast cancer. 63(7). 1223. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manpreet Chadha Breakdown of academic impact, for papers by Miriam Schulz Breakdown of academic impact, for papers by Laetitia Da Meda Breakdown of academic impact, for papers by Pauline Laly Breakdown of academic impact, for papers by Marco Schupp Breakdown of academic impact, for papers by Lisa Wray Breakdown of academic impact, for papers by Julia Krzykalla Breakdown of academic impact, for papers by Mohammed Jaloudi Breakdown of academic impact, for papers by Sisi Yu
Rankless by CCL
2026